Antibiotics for ventilator-associated pneumonia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antibiotics for ventilator-associated pneumonia

Published:2016-10-20 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Arthur Lauren E¹,Kizor Russell S²,Selim Adrian G³,van Driel Mieke L⁴⁵⁶,Seoane Leonardo⁷

Affiliation:

1. School of Medicine, University of Queensland; Ochsner Clinical School; New Orleans LA USA

2. The University of Queensland; School of Medicine; 16/205 Coronation Drive Milton Brisbane Queensland Australia 4064

3. Bond University; Faculty of Health Sciences and Medicine; Gold Coast Qld Australia 4229

4. The University of Queensland; Discipline of General Practice, School of Medicine; Brisbane Queensland Australia 4029

5. Bond University; Centre for Research in Evidence-Based Practice (CREBP); Gold Coast Queensland Australia 4229

6. Ghent University; Department of Family Medicine and Primary Health Care; 1K3, De Pintelaan 185 Ghent Belgium 9000

7. Ochsner Health System; Department of Pulmonary/Critical Care Medicine; 1514 Jefferson Hwy New Orleans LA USA 70121

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004267.pub4/epdf/full

Reference52 articles.

1. Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia;Alvarez Lerma;Journal of Chemotherapy,2001

2. A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia;Awad;Clinical Infectious Diseases,2014

3. Comparative study of the association cefepime-amikacin versus the association ceftazidime-amikacin in the treatment of nosocomial pneumonias in ventilated patients;Beaucaire;Annales Françaises d'Anesthésie et de Réanimation,1999

4. Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial;Brun-Buisson;Clinical Infectious Diseases,1998

5. Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779];Damas;Critical Care,2006

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis of Ventilator-Associated Pneumonia – A Systematic Review and Meta-analysis of Laboratory Techniques;Journal of Pure and Applied Microbiology;2024-07-12

2. Pathogenesis, Diagnosis and Therapeutic Strategies for Ventilator-associated Pneumonia;Journal of Pure and Applied Microbiology;2024-04-27

3. Carbapenem vs. non-carbapenem antibiotics for ventilator-associated pneumonia: A systematic review with meta-analysis;Respiratory Investigation;2024-03

4. Prevalence of Acinetobacter baumannii with multiple drug resistance isolated from patients with ventilator-associated pneumonia from 2010 to 2020 in the world: a systematic review and meta-analysis;REV RES MED MICROBIO;2024

5. Clinical outcomes of fluoroquinolones combination therapy in patients with hospital-acquired pneumonia: a retrospective cohort study using national health insurance claims data in Korea;Journal of Thoracic Disease;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3